Distribution of bla OXA-23, ISAba, Aminoglycosides resistant genes among burned and ICU patients in Tehran and Sari, Iran

Annals of Clinical Microbiology and Antimicrobials

Volumn 13, Issue 1, 2014, Pages

  Nasrolahei, Mohtaram ^a   Zahedi, Bahador ^a   Bahador, Abbas ^b   Saghi, Hossein ^c   Kholdi, Soudeh ^a   Jalalvand, Neda ^d   Esmaeili, Davoud ^c  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Acinetobacter baumannii' bla OXA 23 ' ISAba; Aminoglycoside; Carbapenemase

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIINFECTIVE AGENT; BLA OXA 23; CARBAPENEM DERIVATIVE; COLISTIN; GENTAMICIN; IMIPENEM; IS ABA; KANAMYCIN; MEROPENEM; STREPTOMYCIN; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; AMINOGLYCOSIDE; BETA LACTAM; TRANSPOSON;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BURN; DISK DIFFUSION; DRUG DETERMINATION; DRUG DISTRIBUTION; GENE INSERTION SEQUENCE; HUMAN; INTENSIVE CARE UNIT; IRAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; ACINETOBACTER INFECTIONS; BACTERIAL GENE; COMPLICATION; CRITICAL ILLNESS; CROSS INFECTION; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; TRANSPOSON;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; BURNS; CRITICAL ILLNESS; CROSS INFECTION; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; IRAN; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION;

EID: 84908101006     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/s12941-014-0038-0     Document Type: Article

References (20)

1. Yali G, Jing C, Chunjiang L, Cheng Z, Xiaoqiang L, Yizhi P. Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward. Burns 2013.
2. Rezaei E, Safari H, Naderinasab M, Aliakbarian H. Common pathogens in burn wound and changes in their drug sensitivity. Burns 2011, 37:805-807. 10.1016/j.burns.2011.01.019, 21388742.
3. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010, 65:233-238. 10.1093/jac/dkp428, 19996144.
4. Chul Hee C, Jun Sik L, Yoo Chul L, in Park T, Je Chul L.Acinetobacter baumannii invades epithelial cells and outermembrane protein A mediates interactions with epithelial cells. BMC Microbiol 2008, 8:216. 10.1186/1471-2180-8-216.
5. Joly-Guillou M-L. Clinical impact and pathogenicity of Acinetobacter. Clin Microbial Infect 2005, 11:868-873. 10.1111/j.1469-0691.2005.01227.x.
6. Maragakis LL, Perl TM.Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2007, 46:1254-1263. 10.1086/529198.
7. Barbara Z, Ilaria V. Inhibitors of multidrug resistant efflux systems in bacteria 2009, Bentham Science Publishers Ltd.
8. Sánchez A, Gattarello S, Rello J. New treatment options for infections caused by multiresistant strains of Pseudomonas aeruginosa and other non fermenting gram-negative bacilli. Semin Respir Crit Care Med 2011, 32:151-158. 10.1055/s-0031-1275527, 21506051.
9. Ruiz M, Marti S, Fernandez-Cuenca F, Pascual A, Vila J. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect 2007, 13:1192-1198. 10.1111/j.1469-0691.2007.01825.x, 17850347.
10. Bogaerts P, Cuzon G, Naas T, Bauraing C, Deplano A, Lissoir B, Nordmann P, Glupczynski Y. Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium. Antimicrob Agents Chemother 2008, 52:4205-4206. 10.1128/AAC.01121-08, 18765689.
11. Lee H-Y, Chang R-C, Su L-H, Liu S-Y, Wu S-R, Chuang C-H, Chen CL, Chiu CH. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan. Int J Antimicrob Agents 2012, 40:163-167. 10.1016/j.ijantimicag.2012.04.018, 22743015.
12. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006, 258:72-77. 10.1111/j.1574-6968.2006.00195.x, 16630258.
13. Pajand O, Rezaee MA, Nahaei MR, Mahdian R, Aghazadeh M, Soroush MH. Study of the carbapenem resistance mechanisms in clinical isolates of Acinetobacter baumannii: Comparison of burn and non-burn strains. Burns 2013, 39:1414-1419. 10.1016/j.burns.2013.03.024, 23726475.
14. Asadollahi P, Akbari M, Soroush S, Taherikalani M, Asadollahi K, Sayehmiri K. Antimicrobial resistance patterns and their encoding genes among Acinetobacter baumannii strains isolated from burned patients. Burns 2012, 38:1198-1203. 10.1016/j.burns.2012.04.008, 22579564.
15. Higgins PG, Lehmann M, Wisplinghoff H, Seifert H. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol 2010, 48:4592-4594. 10.1128/JCM.01765-10, 20881170.
16. Wang X, Chen T, Yu R, Lü X, Zong Z.Acinetobacter pittii and Acinetobacter nosocomialis among clinical isolates of the Acinetobacter calcoaceticus-baumannii complex in Sichuan, China. Diagn Microbiol Infect Dis 2013, 76:392-395. 10.1016/j.diagmicrobio.2013.03.020, 23639796.
17. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infec 2012, 18:268-281. 10.1111/j.1469-0691.2011.03570.x.
18. Feizabadi MM, Fathollahzadeh B, Taherikalani M, Rasoolinejad M, Sadeghifard N, Aligholi M. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Jpn J Infect Dis 2008, 61:274-278. 18653968.
19. Joel F, Peleg AY. Treatment of Acinetobacter infections. Clin Infect Dis 2010, 51(1):79-84. 10.1086/653120.
20. Moffatt JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T, Henry R, Crane B, St Michael F, Cox AD, Adler B, Nation RL, Li J, Boyce JD. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother 2010, 54:4971-4977. 10.1128/AAC.00834-10, 20855724.